TAS-205

DRUG2 trials

Sponsors

Taiho Pharmaceutical Co., Ltd.

Conditions

Duchenne Muscular Dystrophy

Phase 1

A Study of TAS-205 for Duchenne Muscular Dystrophy

CompletedNCT02246478

Taiho Pharmaceutical Co., Ltd.Duchenne Muscular Dystrophy

Start: 2014-09-30End: 2015-09-30Updated: 2021-06-04

Phase 2

A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

CompletedNCT02752048

Taiho Pharmaceutical Co., Ltd.Duchenne Muscular Dystrophy

Start: 2016-05-31End: 2017-10-17Updated: 2020-04-20

Related Papers

Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy

Annals of Clinical and Translational Neurology2020-01-2032 citations